Abstract:Background Autoinflammatory diseases are inherited disorders of the innate immune system caused by aberrant activation of the innate immune cells, primarily neutrophils and macrophages. Genetic studies have led to the identification of mutations in 12 genes responsible for various monogenic autoinflammatory diseases, however a significant number of mutation negative patients are sporadic cases or come from small families underpowered for linkage analysis. Objectives To identify disease causing mutation in a family with dominantly inherited inflammatory disease characterized by recurrent blistering skin lesions, pulmonary disease, arthralgia, inflammatory eye, bowel disease, absence of autoantibodies, and mild immunodeficiency manifested by recurrent sino-pulmonary infections. Methods Whole-exome sequencing was performed on three samples, including the affected father and daughter and unaffected mother. Exome data were filtered in more than 6000 exomes to exclude reported variants along with benign variants as determined by PolyPhen-2. A total of eight transcripts were identified as possible candidate genes. Results We confirmed a novel variant, p. S707Y, within the PLCG2 gene as the only de novo variant that was present in two affected and not present in four unaffected family members. PLCG2 encodes phospholipase Cγ2 (PLCγ2), an enzyme with a critical regulatory role in various immune and inflammatory pathways. The S707Y mutation is located in an autoinhibitory SH2 domain that is crucial for PLCγ2 activation. In vitro overexpression of the mutant S707Y protein and ex vivo experiments using patients’ leucocytes showed clearly enhanced PLCγ2 activity suggesting an increased intracellular signaling in the PLCγ2-mediated signaling pathway. Our finding that p. S707Y is hypermorphic mutation in PLCγ2 is further corroborated by animal studies that have implicated the critical role for PLCg2 in regulation of inflammation in mice. Two missense gain-of-function mutations in the murine phospholipase Cg2 (Plcg2) gene introduced by ENU mutagenesis, ALI5 and ALI14, lead to severe spontaneous inflammation and autoimmunity. Conclusions Recently, PLCG2 exon skipping mutations were reported in PLAID patients who present with cold-induced urticaria and immune dysregulation resulting in protein products with constitutive phospholipase activity but with reduced intracellular signaling at physiological temperature (ref). In contrast, we report here a missense PLCG2 mutation as a cause of a distinct inflammatory disease not provoked by cold temperatures, with different end-organ involvement and different cellular phenotype. Our result highlights the utility of exome sequencing technology in finding causal genes in nuclear families with dominantly inherited traits otherwise intractable by linkage analysis. References Ombrello, M.J., Remmers, E.F., Sun, G., Freeman, A.F., Datta, S., Torabi-Parizi, P., Subramanian, N., Bunney, T.D., Baxendale, R.W., Martins, M.S., et al. Cold Urticaria, Immunodeficiency, and Autoimmunity Related to PLCG2 Deletions. N Engl J Med. Disclosure of Interest None Declared

Mimicking Behçet's Disease: GM-CSF Gain of Function Mutation in a Family Suffering from a Behçet's Disease-Like Disorder Marked by Extreme Pathergy.

TNF Inhibitors Target a Mevalonate Metabolite/trpm2/calcium Signaling Axis in Neutrophils to Dampen Vasculitis in Behçet’s Disease

GWAS-identified CCR1 and IL10 loci contribute to M1 macrophage-predominant inflammation in Behçet’s disease

Novel heterozygous C243Y A20/TNFAIP3 gene mutation is responsible for chronic inflammation in autosomal-dominant Behçet's disease

Targeted Resequencing Implicates the Familial Mediterranean Fever Gene MEFV and the Toll-Like Receptor 4 Gene TLR4 in Behçet Disease

Transcriptional analysis of neutrophils from patients with Behçet's disease reveals activation and chemotaxis of neutrophils

Autoinflammatory syndromes mimicking Behçet's disease with gastrointestinal involvement: a retrospective analysis

Genetic and Pharmacological Targeting of GSDMD Ameliorates Systemic Inflammation in Macrophage Activation Syndrome

Lymphocytic Hypophysitis Associated with Behcet's Disease: A Case Report and Review of the Literature.

Behçet's Disease Under Microbiotic Surveillance? A Combined Analysis of Two Cohorts of Behçet's Disease Patients

Novel Insights Into Gene Signatures and Their Correlation With Immune Infiltration of Peripheral Blood Mononuclear Cells in Behcet's Disease

A Hypermorphic Missense Mutation in PLCG2, Encoding Phospholipase Cγ2, Causes a Dominantly Inherited Autoinflammatory Disease with Immunodeficiency.

Profile of immunological biomarkers in Behcet's syndrome: a large-scale single-center real-world study

Aberrant monocyte subsets in patients with Behçet's disease

The Roles of Monocytes and Macrophages in Behçet’s Disease With Focus on M1 and M2 Polarization

Profiling the microbiome of oral and genital mucosal surfaces in Behçet's disease

Novel Heterogeneous Mutation of TNFAIP3 in a Chinese Patient with Behçet-Like Phenotype and Persistent EBV Viremia

Cytokine Signature Differences in Major Phenotypic Groups of Behçet Disease

The Roles of Immune Cells in Behçet’s Disease

OP0174 Exome Sequencing Identifies a Hypermorphic Missense Mutation in the PLCG2 Gene As the Cause of a Dominantly Inherited Autoinflammatory Disease with Immunodeficiency

A biallelic mutation in IL6ST encoding the GP130 co-receptor causes immunodeficiency and craniosynostosis